BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21712021)

  • 1. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L; Taylor MR
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure and personalized medicine.
    Mestroni L; Merlo M; Taylor MR; Camerini F; Sinagra G
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):6-12. PubMed ID: 20814312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of heart failure.
    Mestroni L; Begay RL; Graw SL; Taylor MR
    Curr Opin Cardiol; 2014 May; 29(3):227-34. PubMed ID: 24717669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of heart failure in the course of coronary artery disease--the role of genetic factors].
    Kozieradzka A; Kamiński K; Musiał WJ
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S440-9. PubMed ID: 20527399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of play of pharmacogenetics and personalized medicine in heart failure.
    Parry HM; Doney AS; Palmer CN; Lang CC
    Cardiovasc Ther; 2013 Dec; 31(6):315-22. PubMed ID: 23480579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic polymorphisms on heart failure prognosis.
    Le Corvoisier P; Park HY; Carlson KM; Donahue MP; Marchuk DA; Rockman HA
    Arch Mal Coeur Vaiss; 2003 Mar; 96(3):197-206. PubMed ID: 12722550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for personalized medicine-based research and implementation in the clinical workflow.
    Lieb W; Völzke H; Pulley JM; Roden DM; Kroemer HK
    Clin Pharmacol Ther; 2012 Oct; 92(4):443-5. PubMed ID: 22910438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifier genes and heart failure.
    Le Corvoisier P; Park HY; Rockman HA
    Minerva Cardioangiol; 2003 Apr; 51(2):107-20. PubMed ID: 12783067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential benefits and limitations of new technologies in the personalized treatment of depression].
    Carlino D; De Vanna M
    Riv Psichiatr; 2011; 46(3):155-71. PubMed ID: 21779096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to drug development in heart failure: towards personalized medicine.
    Liu LC; Voors AA; Valente MA; van der Meer P
    Can J Cardiol; 2014 Mar; 30(3):288-95. PubMed ID: 24565253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
    Kager L
    J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.